Evaluation efficacy of probiotics on some inflammatory factors of ICU cases

Evaluation of the effect of probiotic administration of interleukins 6 and 10 levels in poisoned patients admitted to ICU of Loghman hospital in 1400

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20210720051946N5

Enrollment

100

Registered

2022-10-06

Start date

2022-10-23

Completion date

Unknown

Last updated

2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intoxication. Other bacterial foodborne intoxications, not elsewhere classified

Interventions

Intervention 1: Control group: For seven days, TDS received placebo. Intervention 2: Intervention group: For seven days TDS received two probiotic capsules as gavage.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with poisoning Admission to the ICU Receive enteral nutrition ICU admission for at least seven days

Exclusion criteria

Exclusion criteria: Intestinal obstruction Renal failure Pancreatitis Short bowel syndrome History of chemotherapy

Design outcomes

Primary

Measure	Time frame
IL-6. Timepoint: Before treatment and after complete period of treatment. Method of measurement: kgf kit.;IL-10. Timepoint: Before treatment and after complete period of treatment. Method of measurement: kgf kit.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactPeyman Erfan Talab Evini

Shahid Beheshti University of Medical Sciences

peyman1346erfan@sbmu.ac.ir+98 21 5102 5000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026